Publication

171.
Nagaoka H, Kanoi BN, Jinoka K, Morita M, Arumugam TU, Palacpac NMQ, Egwang TG, Horii T, Tsuboi T, Takashima E (2019) The N-Terminal region of Plasmodium falciparum MSP10 is a target of protective antibodies in Malaria and is important for PfGAMA/PfMSP10 interaction. Front. Immunol. 10:2669. doi: 10.3389/fimmu.2019.02669
170.
Iriko H, Ishino T, Tachibana M, Omoda A, Torii M, Tsuboi T. Skeleton binding protein 1 (SBP1) of Plasmodium falciparum accumulates in electron-dense material before passing through the parasitophorous vacuole membrane. Parasitol Int. 2019 Oct 26:102003. doi: 10.1016/j.parint.2019.102003.
169.
Miura K, Tachibana M, Takashima E, Morita M, Kanoi BN, Nagaoka H, Baba M,Torii M, Ishino T, Tsuboi T. Malaria transmission-blocking vaccines: wheat germ
cell-free technology can accelerate vaccine development. Expert Rev Vaccines. 2019 Oct;18(10):1017-1027. doi: 10.1080/14760584.2019.1674145.
168.
Tokunaga N, Nozaki M, Tachibana M, Baba M, Matsuoka K, Tsuboi T, Torii M, Ishino T. Expression and Localization Profiles of Rhoptry Proteins in Plasmodium berghei Sporozoites. Front Cell Infect Microbiol. 2019 Sep 10;9:316. doi: 10.3389/fcimb.2019.00316.
167.
Chan JA, Wetzel D, Reiling L, Miura K, Drew DR, Gilson PR, Anderson DA, Richards JS, Long CA, Suckow M, Jenzelewski V, Tsuboi T, Boyle MJ, Piontek M, Beeson JG. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity. PLoS One. 2019 Sep 10;14(9):e0221733. doi: 10.1371/journal.pone.0221733.
166.
Low LM, Azasi Y, Sherling ES, Garten M, Zimmerberg J, Tsuboi T, Brzostowski J, Mu J, Blackman MJ, Miller LH. Deletion of Plasmodium falciparum Protein RON3
Affects the Functional Translocation of Exported Proteins and Glucose Uptake. MBio. 2019 Jul 9;10(4). pii: e01460-19. doi: 10.1128/mBio.01460-19.
165.
Bantuchai S, Nozaki M, Thongkukiatkul A, Lorsuwannarat N, Tachibana M, Baba M, Matsuoka K, Tsuboi T, Torii M, Ishino T. Rhoptry neck protein 11 has crucial roles during malaria parasite sporozoite invasion of salivary glands and hepatocytes. Int J Parasitol. 2019 Aug;49(9):725-735. doi: 10.1016/j.ijpara.2019.05.001.
164.
Yusuf Y, Yoshii T, Iyori M, Yoshida K, Mizukami H, Fukumoto S, Yamamoto DS, Alam A, Emran TB, Amelia F, Islam A, Otsuka H, Takashima E, Tsuboi T, Yoshida S. Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming. Front Immunol. 2019 Apr 5;10:730. doi: 10.3389/fimmu.2019.00730.
163.
Nagaoka H, Sasaoka C, Yuguchi T, Kanoi BN, Ito D, Morita M, Udomsangpetch R, Sattabongkot J, Ishino T, Tsuboi T, Takashima E. PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47). Sci Rep. 2019 Apr 11;9(1):5923. doi: 10.1038/s41598-019-42366-9.
162.
Tachibana M, Miura K, Takashima E, Morita M, Nagaoka H, Zhou L, Long CA, Richter King C, Torii M, Tsuboi T, Ishino T. Identification of domains within Pfs230 that elicit transmission blocking antibody responses. Vaccine. 2019 Mar 22;37(13):1799-1806. doi: 10.1016/j.vaccine.2019.02.021.
161.
Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJI, Takashima E, Tsuboi T, Mueller I, Beeson JG. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat Commun. 2019 Feb 5;10(1):610. doi: 10.1038/s41467-019-08528-z.
160.
Jenwithisuk R, Kangwanrangsan N, Tachibana M, Thongkukiatkul A, Otsuki H, Sattabongkot J, Tsuboi T, Torii M, Ishino T. Identification of a PH domain-containing protein which is localized to crystalloid bodies of Plasmodium ookinetes. Malar J. 2018 Dec 13;17(1):466. doi: 10.1186/s12936-018-2617-6.
159.
Tachibana M, Ishino T, Tsuboi T, Torii M. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes. Vaccine. 2018 Nov 26;36(49):7463-7471. doi: 10.1016/j.vaccine.2018.10.067.
158.
Tohmoto T, Takashima E, Takeo S, Morita M, Nagaoka H, Udomsangpetch R, Sattabongkot J, Ishino T, Torii M, Tsuboi T. Anti-MSP11 IgG inhibits Plasmodium falciparum merozoite invasion into erythrocytes in vitro. Parasitol Int. 2019 Apr;69:25-29. doi: 10.1016/j.parint.2018.10.012.
157.
Ito D, Takashima E, Yamasaki T, Hatano S, Hasegawa T, Miura K, Morita M, Thongkukiatkul A, Diakite M, Long CA, Sattabongkot J, Udomsangpetch R, Iriko H, Ishino T, Tsuboi T. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes. Parasitol Int. 2019 Feb;68(1):87-91. doi: 10.1016/j.parint.2018.10.006.
156.
Ishino T, Murata E, Tokunaga N, Baba M, Tachibana M, Thongkukiatkul A, Tsuboi T, Torii M. Rhoptry neck protein 2 expressed in Plasmodium sporozoites plays a crucial role during invasion of mosquito salivary glands. Cell Microbiol. 2019 Jan;21(1):e12964. doi: 10.1111/cmi.12964.
155.
Oda-Yokouchi Y, Tachibana M, Iriko H, Torii M, Ishino T, Tsuboi T. Plasmodium RON12 localizes to the rhoptry body in sporozoites. Parasitol Int. 2019 Feb;68(1):17-23. doi: 10.1016/j.parint.2018.10.001.
154.
Kanoi BN, Nagaoka H, Morita M, White MT, Palacpac NMQ, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T, Takashima E. Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains. Vaccine. 2018 Oct 29;36(45):6826-6833. doi: 10.1016/j.vaccine.2018.08.058.
153.
Ishino T, Tsuboi T. Progress toward a transmission-blocking vaccine against malaria. Lancet Infect Dis. 2018 Sep;18(9):927-928. doi: 10.1016/S1473-3099(18)30358-X.
152.
Iriko H, Ishino T, Otsuki H, Ito D, Tachibana M, Torii M, Tsuboi T. Plasmodium falciparum Exported Protein 1 is localized to dense granules in merozoites. Parasitol Int. 2018 Oct;67(5):637-639. doi: 10.1016/j.parint.2018.06.001.
151.
Liu F, Li L, Zheng W, He Y, Wang Y, Zhu X, Tsuboi T, Cui L, Wang M, Cao Y. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential. Infect Immun. 2018 Jul 23;86(8). pii: e00785-17. doi: 10.1128/IAI.00785-17.
150.
Miura T, Takeo S, Ntege EH, Otsuki H, Sawasaki T, Ishino T, Takashima E, Tsuboi T. The malaria parasite RhopH protein complex interacts with erythrocyte calmyrin identified from a comprehensive erythrocyte protein library. Biochem Biophys Res Commun. 2018 Jun 2;500(2):261-267. doi: 10.1016/j.bbrc.2018.04.056.
149.
Tougan T, Edula JR, Takashima E, Morita M, Shinohara M, Shinohara A, Tsuboi T, Horii T. Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5. Sci Rep. 2018 Mar 22;8(1):5052. doi: 10.1038/s41598-018-23194-9.
148.
Ikeda M, Kaneko M, Tachibana SI, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, Takahashi N, Yamauchi M, Sekihara M, Hashimoto M, Katuro OT, Olia A, Obwoya PS, Auma MA, Anywar DA, Odongo-Aginya EI, Okello-Onen J, Hirai M, Ohashi J, Palacpac NMQ, Kataoka M, Tsuboi T, Kimura E, Horii T, Mita T. Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016. Emerg Infect Dis. 2018 Apr;24(4):718-726. doi: 10.3201/eid2404.170141.
147.
Morita M, Nagaoka H, Ntege EH, Kanoi BN, Ito D, Nakata T, Lee JW, Tokunaga K, Iimura T, Torii M, Tsuboi T, Takashima E. PV1, a novel Plasmodium falciparum merozoite dense granule protein, interacts with exported protein in infected erythrocytes. Sci Rep. 2018 Feb 27;8(1):3696. doi: 10.1038/s41598-018-22026-0.
146.
Tachibana M, Ishino T, Takashima E, Tsuboi T, Torii M. A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation. Cell Microbiol. 2018 May;20(5):e12821. doi: 10.1111/cmi.12821.
145.
Sakamoto H, Takeo S, Takashima E, Miura K, Kanoi BN, Kaneko T, Han ET, Tachibana M, Matsuoka K, Sattabongkot J, Udomsangpetch R, Ishino T, Tsuboi T. Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission. Parasitol Int. 2018 Apr;67(2):203-208. doi: 10.1016/j.parint.2017.12.002.
144.
Saito F, Hirayasu K, Satoh T, Wang CW, Lusingu J, Arimori T, Shida K, Palacpac NMQ, Itagaki S, Iwanaga S, Takashima E, Tsuboi T, Kohyama M, Suenaga T, Colonna M, Takagi J, Lavstsen T, Horii T, Arase H. Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors. Nature. 2017 Dec 7;552(7683):101-105. doi: 10.1038/nature24994.
143.
França CT, White MT, He WQ, Hostetler JB, Brewster J, Frato G, Malhotra I, Gruszczyk J, Huon C, Lin E, Kiniboro B, Yadava A, Siba P, Galinski MR, Healer J, Chitnis C, Cowman AF, Takashima E, Tsuboi T, Tham WH, Fairhurst RM, Rayner JC, King CL, Mueller I. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. Elife. 2017 Sep 26;6. pii: e28673. doi: 10.7554/eLife.28673.
142.
Longley RJ, White MT, Takashima E, Morita M, Kanoi BN, Li Wai Suen CSN, Betuela I, Kuehn A, Sripoorote P, Franca CT, Siba P, Robinson LJ, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I. Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions. PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005888. doi: 10.1371/journal.pntd.0005888.
141.
Ntege EH, Takashima E, Morita M, Nagaoka H, Ishino T, Tsuboi T. Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates. Expert Rev Vaccines. 2017 Aug;16(8):769-779. doi: 10.1080/14760584.2017.1341317.
140.
Cheng Y, Wang B, Changrob S, Han JH, Sattabongkot J, Ha KS, Chootong P, Lu F, Cao J, Nyunt MH, Park WS, Hong SH, Lim CS, Tsuboi T, Han ET. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection. Malar J. 2017 May 22;16(1):211. doi: 10.1186/s12936-017-1837-5.
139.
McLean ARD, Boel M, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJI. Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum. Am J Trop Med Hyg. 2017 May;96(5):1197-1204. doi: 10.4269/ajtmh.16-0690.
138.
Morita M, Takashima E, Ito D, Miura K, Thongkukiatkul A, Diouf A, Fairhurst RM, Diakite M, Long CA, Torii M, Tsuboi T. Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate. Sci Rep. 2017 Apr 5;7:46086. doi: 10.1038/srep46086.
137.
Muh F, Han JH, Nyunt MH, Lee SK, Jeon HY, Ha KS, Park WS, Hong SH, Ahmed MA, Na S, Takashima E, Tsuboi T, Han ET. Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180. Malar J. 2017 Mar 28;16(1):133. doi: 10.1186/s12936-017-1760-9.
136.
Ataide R, Ashley EA, Powell R, Chan JA, Malloy MJ, O’Flaherty K, Takashima E, Langer C, Tsuboi T, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJ. Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort. Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3515-3520. doi: 10.1073/pnas.1615875114.
135.
Kanoi BN, Takashima E, Morita M, White MT, Palacpac NM, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda. Vaccine. 2017 Feb 7;35(6):873-881. doi: 10.1016/j.vaccine.2017.01.001.
134.
Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NM, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda. Malar J. 2017 Jan 9;16(1):23. doi: 10.1186/s12936-016-1663-1.

133.
Zheng W, Liu F, He Y, Liu Q, Humphreys GB, Tsuboi T, Fan Q, Luo E, Cao Y, Cui L. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate. Parasit Vectors. 2017 Jan 5;10(1):8. doi: 10.1186/s13071-016-1932-4.

132.
Bargieri DY, Thiberge S, Tay CL, Carey AF, Rantz A, Hischen F, Lorthiois A, Straschil U, Singh P, Singh S, Triglia T, Tsuboi T, Cowman A, Chitnis C, Alano P, Baum J, Pradel G, Lavazec C, Ménard R. Plasmodium Merozoite TRAP Family Protein Is Essential for Vacuole Membrane Disruption and Gamete Egress from Erythrocytes. Cell Host Microbe. 2016 Nov 9;20(5):618-630. doi: 10.1016/j.chom.2016.10.015.

131.
Kerkhof K, Sluydts V, Willen L, Kim S, Canier L, Heng S, Tsuboi T, Sochantha T, Sovannaroth S, Ménard D, Coosemans M, Durnez L. Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J. 2016 Nov 4;15(1):529.
130.
Ntege EH, Arisue N, Ito D, Hasegawa T, Palacpac NMQ, Egwang TG, Horii T, Takashima E, Tsuboi T. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Vaccine. 2016 Nov 4;34(46):5612-5622. doi: 10.1016/j.vaccine.2016.09.028.
129.
Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, Kong DH, Jiang L, Wu J, Ha KS, Takashima E, Sattabongkot J, Cao J, Nyunt MH, Kyaw MP, Desai SA, Miller LH, Tsuboi T, Han ET. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status. Sci Rep. 2016 Oct 19;6:35581. doi: 10.1038/srep35581.
128.
Weaver R, Reiling L, Feng G, Drew DR, Mueller I, Siba PM, Tsuboi T, Richards JS, Fowkes FJI, Beeson JG. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria. Sci Rep. 2016 Sep 8;6:33094. doi: 10.1038/srep33094.
127.
McLean AR, Boel ME, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJ. Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period. Sci Rep. 2016 Aug 25;6:32159. doi: 10.1038/srep32159.
126.
Han JH, Lee SK, Wang B, Muh F, Nyunt MH, Na S, Ha KS, Hong SH, Park WS, Sattabongkot J, Tsuboi T, Han ET.
Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain.
Sci Rep. 2016 May 31;6:26993. doi: 10.1038/srep26993.
125.
Duffy MF, Noviyanti R, Tsuboi T, Feng ZP, Trianty L, Sebayang BF, Takashima E, Sumardy F, Lampah DA, Turner L, Lavstsen T, Fowkes FJ, Siba P, Rogerson SJ, Theander TG, Marfurt J, Price RN, Anstey NM, Brown GV, Papenfuss AT.
Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.
Malar J. 2016 May 5;15(1):258. doi: 10.1186/s12936-016-1296-4.
124.
Zheng W, Kou X, Du Y, Liu F, Yu C, Tsuboi T, Fan Q, Luo E, Cao Y, Cui L.
Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.
Vaccine. 2016 May 17;34(23):2570-8. doi: 10.1016/j.vaccine.2016.04.011.
123.
Changrob S, Wang B, Han JH, Lee SK, Nyunt MH, Lim CS, Tsuboi T, Chootong P, Han ET.
Correction: Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.
PLoS One. 2016 Mar 31;11(3):e0153110. doi: 10.1371/journal.pone.0153110.
122.
Charnaud SC, McGready R, Herten-Crabb A, Powell R, Guy A, Changrob S, Wang B, Han JH, Lee SK, Nyunt MH, Lim CS, Tsuboi T, Chootong P, Han ET.
Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.
PLoS One. 2016 Feb 17;11(2):e0148723. doi: 10.1371/journal.pone.0148723. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0153110. PLoS One. 2016;11(5):e0156011.
121.
Aguiar JC, Bolton J, Wanga J, Sacci JB, Iriko H, Mazeika JK, Han ET, Limbach K, Patterson NB, Sedegah M, Cruz AM, Tsuboi T, Hoffman SL, Carucci D, Hollingdale MR, Villasante ED, Richie TL.
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
PLoS One. 2015 Aug 20;10(8):e0136109. doi: 10.1371/journal.pone.0136109. eCollection 2015.
120.
Lin CS, Uboldi AD, Epp C, Bujard H, Tsuboi T, Czabotar PE, Cowman AF.
Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes.
J Biol Chem. 2016 Apr 1;291(14):7703-15. doi: 10.1074/jbc.M115.698282.
119.
Mitri C, Bischoff E, Takashima E, Williams M, Eiglmeier K, Pain A, Guelbeogo WM, Gneme A, Brito-Fravallo E, Holm I, Lavazec C, Sagnon N, Baxter RH, Riehle MM, Vernick KD.
An Evolution-Based Screen for Genetic Differentiation between Anopheles Sister Taxa Enriches for Detection of Functional Immune Factors.
PLoS Pathog. 2015 Dec 3;11(12):e1005306. doi: 10.1371/journal.ppat.1005306. eCollection 2015 Dec.
118.
Tsuboi T, Takashima E.
Antibody titre as a surrogate of protection of the first malaria subunit vaccine, RTS,S/AS01.
Lancet Infect Dis. 2015 Dec;15(12):1371-2. doi: 10.1016/S1473-3099(15)00300-X.
117.
Aguiar JC, Bolton J, Wanga J, Sacci JB, Iriko H, Mazeika JK, Han ET, Limbach K, Patterson NB, Sedegah M, Cruz AM, Tsuboi T, Hoffman SL, Carucci D, Hollingdale MR, Villasante ED, Richie TL.
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
PLoS One. 2015 Aug 20;10(8):e0136109. doi: 10.1371/journal.pone.0136109. eCollection 2015.
116.
Cheng Y, Lu F, Lee SK, Kong DH, Ha KS, Wang B, Sattabongkot J, Tsuboi T, Han ET.
Characterization of Plasmodium vivax Early Transcribed Membrane Protein 11.2 and Exported Protein 1.
PLoS One. 2015 May 26;10(5):e0127500. doi: 10.1371/journal.pone.0127500. eCollection 2015.
115.
Wu Y, Sinden RE, Churcher TS, Tsuboi T, Yusibov V.
Development of malaria transmission-blocking vaccines: from concept to product.
Adv Parasitol. 2015 Jun;89:109-52. doi: 10.1016/bs.apar.2015.04.001.
114.
Wang B, Lu F, Cheng Y, Chen JH, Jeon HY, Ha KS, Cao J, Nyunt MH, Han JH, Lee SK, Kyaw MP, Sattabongkot J, Takashima E, Tsuboi T, Han ET.
Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax. Infect Immun. 2015 Aug;83(8):3083-95. doi: 10.1128/IAI.03067-14.
113.
Cheng Y, Li J, Ito D, Kong DH, Ha KS, Lu F, Wang B, Sattabongkot J, Lim CS, Tsuboi T, Han ET.
Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein.
Malar J. 2015
112.
Changrob S, Leepiyasakulchai C, Tsuboi T, Cheng Y, Lim CS, Chootong P, Han ET.
Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen.
Malar J. 2015
111.
Hayakawa EH, Tokumasu F, Usukura J, Matsuoka H, Tsuboi T, Wellems TE.
Imaging of the subsurface structures of “unroofed” Plasmodium falciparum-infected erythrocytes.
Exp Parasitol. 2015 Jun;153:174-9.
110.
Tachibana M, Suwanabun N, Kaneko O, Iriko H, Otsuki H, Sattabongkot J, Kaneko A, Herrera S, Torii M, Tsuboi T.
Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Vaccine. 2015 Apr 15;33(16):1901-8.
109.
Otsuki H, Yokouchi Y, Iyoku N, Tachibana M, Tsuboi T, Torii M.
The rodent malaria lactate dehydrogenase assay provides a high throughput solution for in vivo vaccine studies.
Parasitol Int. 2015 Feb 19;64(4):60-63.
108.
Tanabe K, Zollner G, Vaughand JA, Sattabongkot J, Khuntirat B, Honma H, Mita T, Tsuboi T, Coleman R
Plasmodium falciparum: Genetic diversity and complexity of infections in an isolated village in western Thailand.
Parasitol Int.  2015 Jun;64(3):260-6
107.
Fujii Y, Kaneko S, Nzou SM, Mwau M, Njenga SM, Tanigawa C, Kimotho J, Mwangi AW, Kiche I, Matsumoto S, Niki M, Osada-Oka M, Ichinose Y, Inoue M, Itoh M, Tachibana H, Ishii K, Tsuboi T, Yoshida LM, Mondal D, Haque R, Hamano S, Changoma M, Hoshi T, Kamo K, Karama M, Miura M, Hirayama K
Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models.
PLoS Negl Trop Dis. 2014, 8(7): e3040.
106.
Cheng Y, Wang B, Sattabongkot J, Lim CS, Tsuboi T, Han ET
Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.
Parasitol Res. 2014, 113(7):2559-68.
105.
Cheng Y, Shin EH, Lu F, Wang B, Choe J, Tsuboi T, Han ET.
Antigenicity studies in humans and immunogenicity studies in mice: an MSP1P subdomain as a candidate for malaria vaccine development.
Microbes Infect. 2014, 16(5):419-28.
104.
Lu F, Li J, Wang B, Cheng Y, Kong DH, Cui L, Ha KS, Sattabongkot J, Tsuboi T, Han ET
Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA).
J Proteomics. 2014, 102:66-82.
103.
Sattabongkot J, Tsuboi T, Han ET, Bantuchai S, Buates S
Loop-mediated isothermal amplification assay for rapid diagnosis of malaria infections in an area of endemicity in Thailand.
J Clin Microbiol. 2014, 52(5):1471-1477.
102.
Arakawa T, Tsuboi T, Sattabongkot J, Sakao K, Torii M, Miyata T
Tricomponent complex loaded with a mosquito-stage antigen of malaria parasite induces potent transmission-blocking immunity.
Clin Vaccine Immunol. 2014, 21(4):561-569.
101.
Arumugam TU, Ito D, Takashima E, Tachibana M, Ishino T, Torii M, Tsuboi T
Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery.
Expert Rev Vaccines. 2014, 13(1):75-85.
100.
Kaneko A, Chaves L, Taleo G, Kalkoa M, Isozumi R, Wickremasinghe R, Perlmann H, Takeo S, Tsuboi T, Tachibana S-I, Kimura M, Björkman A, Troye-Blomberg M, Tanabe K, Drakeley C
Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum island.
Infect Immun. 2014, 82(1):243-252.
99.
Mathias DK, Pastrana-Mena R, Ranucci E, Ferruti P, de Beaumont C, Ortega C, Staples GO, Zaia J, Takashima E, Tsuboi T, Verotta L, Dinglasan RR
A small molecule glycosaminoglycan mimetic blocks Plasmodium invasion of the mosquito midgut.
PLoS Pathogens. 2013, 9(11):e1003757.
98.
Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T
Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
Infect Immun. 2013, 81(12):4377-4382.
97.
Ito D, Hasegawa T, Miura K, Yamasaki T, Arumugam TU, Thonkukiatkul A, Takeo S, Takashima E, Sattabongkot J, Han ET, Long CA, Torii M, Tsuboi T
RALP1 is a rhoptry-neck erythrocyte-binding protein of Plasmodium falciparum merozoite and a potential blood-stage vaccine candidate antigen.
Infect Immun. 2013, 81(11):4290-4298.
96.
Cheng Y, Ito D, Sattabongkot J, Lim SL, Kong DH, Ha KS, Wang B, Tsuboi T, Han ET
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.
Malaria J. 2013, 12(1):323.
95.
Richards JS, Arumugam TU, Reiling L, Healer J, Hodder AN, Fowkes FJI, Cross N, Langer C, Takeo S, Uboldi AD, Thompson JK, Gilson PR, Coppel RL, Siba PM, King CL, Torii M, Chitnis CE, Narum DL, Mueller I, Crabb BS, Cowman AF, Tsuboi T, Beeson JG.
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.
J Immunol. 2013, 191:795-809.
94.
Shinzawa N, Ishino T, Tachibana M, Tsuboi T, Torii M.
Phenotypic dissection of a Plasmodium-refractory strain of malaria vector Anopheles stephensi: The reduced susceptibility to P. berghei and P. yoelii.
PLoS One. 2013, 8(5):e63753.
93.
Kangwanrangsan N, Tachibana M, Jenwithisuk R, Tsuboi T, Riengrojpitak S, Torii M, Ishino T.
A member of the CPW-WPC protein family is expressed in and localized to the surface of developing ookinetes.
Malar J. 2013, 12(1):129.
92.
Cheng Y, Lu F, Tsuboi T, Han ET.
Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41.
Acta Trop. 2013, 126(3):222-228.
91.
Cheng Y, Wang Y, Ito D, Kong DH, Ha KS, Chen JH, Lu F, Li J, Wang B, Takashima E, Sattabongkot J, Tsuboi T, Han ET.
PvMSP1P, merozoite surface protein 1 paralog, is a novel erythrocyte-binding ligand of Plasmodium vivax.
Infect Immun. 2013, 81(5):1585-1595.
90.
Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL.
Natural Acquisition of Immunity to Plasmodium vivax: Epidemiological Observations and Potential Targets. in: Rollinson D, (Ed.), The Epidemiology of Plasmodium vivax: History, Hiatus and Hubris, Part B, Academic Press, Adv Parasitol. 2013, 81:77-131.
89.
Wang B, Lu F, Cheng Y, Li J, Ito D, Sattabongkot J, Tsuboi T, Han ET.
Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.
Parasitol Res. 2013, 112(2):585-93.
87.
Holm I, Lavazec C, Garnier T, Mitri C, Riehle MM, Bischoff E, Brito-Fravallo E, Takashima E, Thiery I, Zettor A, Petres S, Bourgouin C, Vernick KD, Eiglmeier K.
Diverged alleles of the Anopheles gambiae leucine-rich repeat gene APL1A display distinct protective profiles against Plasmodium falciparum. PLoS One. 2012;7(12):e52684.
86.
Zhu X, Yahata K, Alexandre JS, Tsuboi T, Kaneko O.
The N-terminal segment of Plasmodium falciparum SURFIN(4.1) is required for its trafficking to the red blood cell cytosol through the endoplasmic reticulum.
Parasitol Int. 2012, 62(2):215-229.
85.
Fowkes FJ, McGready R, Cross NJ, Hommel M, Simpson JA, Elliott SR, Richards JS, Lackovic K, Viladpai-Nguen J, Narum D, Tsuboi T, Anders RF, Nosten F, Beeson JG.
New insights into acquisition, boosting and longevity of immunity to malaria in pregnant women.
J Infect Dis. 2012, 206(10):1612-21.
84.
Kitamura K, Kishi-Itakura C, Tsuboi T, Sato S, Kita K, Ohta N, Mizushima N.
Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria Parasite Plasmodium falciparum.
PLoS One. 2012, 7(8):e42977.
83.
Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET.
Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry.
Parasitol Int. 2012, 61:443-449.
82.
Bullen HE, Charnaud SC, Kalanon M, Riglar DT, Dekiwadia C, Kangwanrangsan N, Torii M, Tsuboi T, Baum J, Ralph SA, Cowman AF, de Koning-Ward TF, Crabb BS, Gilson PR.
Biosynthesis, localisation and macromolecular arrangement of the Plasmodium falciparum translocon of exported proteins; PTEX.
J Biol Chem. 2012, 287(11):7871-7884.
81.
Tonwong N, Sattabongkot J, Tsuboi T, Iriko H, Takeo S, Sirichaisinthop J, Udomsangpetch R.
Natural infection of Plasmodium falciparum induces inhibitory antibodies against gametocyte development in human hosts.
Jpn J Infect Dis. 2012, 65(2):152-156.
80.
Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, Sattabongkot J, Nakamura M, Sakurai M, Kobayashi J, Kaneko A, Endo H, Hombhanje F, Tsuboi T, Mita T.
Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.
Malar J. 2012, 11(1):92.
79.
Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T.
Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
Vaccine. 2012, 30:1972-1980.
78.
Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T.
Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate.
Vaccine. 2012, 30:1807-1812.
77.
Volz JC, Bártfai R, Petter M, Langer C, Josling GA, Tsuboi T, Schwach F, Baum J, Rayner JC, Stunnenberg HG, Duffy MF, Cowman AF.
PfSET10, a Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division.
Cell Host Microbe. 2012;11(1):7-18.
76.
Ord RL, Rodriguez M, Yamasaki T, Takeo S, Tsuboi T, Lobo CA.
Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum.
PLoS One. 2012;7(1):e30251.
75.
Lu F, Gao Q, Zhou H, Cao J, Wang W, Lim CS, Na S, Tsuboi T, Han ET.
Molecular test for vivax malaria with loop-mediated isothermal amplification method in central China.
Parasitol Res. 2012, 110:2439-2444.
74.
Sungkapong T, Culleton R, Yahata K, Tachibana M, Ruengveerayuth R, Udomsangpetch R, Torii M, Tsuboi T, Sattabongkot J, Kaneko O, Chotivanich K.
Humoral immune responses to Plasmodium vivax subtelomeric transmembrane proteins in Thailand.
Southeast Asian J Trop Med Public Health. 2011, 42(6):1313-1321.
73.
ildiz Zeyrek F, Palacpac N, Yuksel F, Yagi M, Honjo K, Fujita Y, Arisue N, Takeo S, Tanabe K, Horii T, Tsuboi T, Ishii KJ, Coban C.
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.
PLoS One. 2011;6(11):e28126.
72.
Cherif MS, Shuaibu MN, Kurosaki T, Helegbe GK, Kikuchi M, Yanagi T, Tsuboi T, Sasaki H, Hirayama K
Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration.
Vaccine. 2011, 29:9038-9050.
71.
Nozawa A, Fujimoto R, Matsuoka H, Tsuboi T, Tozawa Y.
Cell-free synthesis, reconstitution, and characterization of a mitochondrial dicarboxylate-tricarboxylate carrier of Plasmodium falciparum.
Biochem Biophys Res Commun. 2011, 414:612–617.
70.
Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T
Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.
Infect Immun. 2011, 79:4523-4532.
69.
Sirichaisinthop J, Buates S, Watanabe R, Han ET, Suktawonjaroenpon W, Krasaesub S, Takeo S, Tsuboi T, Sattabongkot J
Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting.
Am J Trop Med Hyg. 2011, 85:594-596.
68.
Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Ikehara A, Tachibana M, Torii M, Matsuzaki G, Arakawa T.
Tricomponent immunopotentiating system (TIPS) as a novel molecular design strategy for malaria vaccine development.
Infect Immun. 2011, 79:4260-4275.
67.
Rui E, Fernandez-Becerra C, Takeo S, Sanz S, Lacerda MV, Tsuboi T, Del Portillo HA.
Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays.
Malar J. 2011, 10:192.
66.
Farrance CE, Rhee A, Jones RM, Musiychuk K, Shamloul M, Sharma S, Mett V, Chichester JA, Streatfield SJ, Roeffen W, van de Vegte-Bolmer M, Sauerwein RW, Tsuboi T, Muratova OV, Wu Y, Yusibov V.
A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum.
Clin Vaccine Immunol. 2011, 18:1351-1357.
65.
Tachibana M, Wu Y, Iriko H, Muratova O, Macdonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T.
N-terminal pro-domain of Pfs230 synthesized using cell-free system is sufficient to induce the complement dependent malaria transmission-blocking activity.
Clin Vaccine Immunol. 2011, 18:1343-1350.
64.
Doi M, Tanabe K, Tachibana SI, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T.
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.
Vaccine. 2011, 29:4308-4315.
63.
Chen JH, Wang Y, Ha KS, Lu F, Suh IB, Lim CS, Park JH, Takeo S, Tsuboi T, Han ET.
Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays.
Parasitol Res. 2011, 109:1259–1266.
62.
Ito D, Han ET, Takeo S, Thongkukiatkul A, Otsuki H, Torii M, Tsuboi T.
Plasmodial ortholog of Toxoplasma gondii rhoptry neck protein 3 is localized to the rhoptry body.
Parasitol Int. 2011, 60: 132-138.
61.
Miyata T, Harakuni T, Sugawa H, Sattabongkot J, Kato A, Tachibana M, Torii M, Tsuboi T, Arakawa T.
Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine.
Vaccine. 2011, 29:2720-2726.
60.
Wang Y, Kaneko O, Sattabongkot J, Chen JH, Lu F, Chai JY, Takeo S, Tsuboi T, Ayala FJ, Chen Y, Lim CS, Han ET.
Genetic polymorphism of Plasmodium vivax msp1p, a paralog of merozoite surface protein 1, from worldwide isolates.
Am J Trop Med Hyg. 2011, 84: 292-297.
59. Takashima, E., Yamada, H., Yamashita, T., Matsushita, K., Konishi, K.Recombinant expression and redox properties of triheme c membrane-bound quinol peroxidase.
FEMS Microbiol Lett. 2010; 302:52-57
58.
Takashima, E., Yamada, H., Yajima, A., Shiomi, K., Ōmura, S., Konishi, K.
A quinol peroxidase inhibitor prevents a secretion of a leukotoxin from Aggregatibacter actinomycetemcomitans.
J Periodontal Res. 2010; 45:123-128
57.
hen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET.
Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays.
J Proteome Res. 2010, 9: 6479-6489.
56.
lagborough AM, Yoshida S, Sattabongkot J, Tsuboi T, Sinden RE.
Intranasal and intramuscular immunization with baculovirus dual expression system-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission.
Vaccine. 2010, 28: 6014-6020.
55.
Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Kohama H, Tachibana M, Matsuzaki G, Torii M, Arakawa T.
Plasmodium vivax ookinete surface protein, Pvs25, linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization.
Infect Immun. 2010, 78: 3773-3782.
54.
Buates S, Bantuchai S, Sattabongkot J, Han ET, Tsuboi T, Udomsangpetch R, Sirichaisinthop J, Tan-Ariya P.
Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) for clinical detection of Plasmodium falciparum gametocytes.
Parasitol Int. 2010, 59: 414-420.
53.
Tsuboi T, Takeo S, Arumugam TU, Otsuki H, Torii M.
The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery.
Acta Trop. 2010, 114: 171-176.
52.
Tsuboi T, Takeo S, Sawasaki T, Torii M, Endo Y.
An efficient approach to the production of vaccines against the malaria parasite. In Cell-Free Protein Production. Ed. Endo Y.
Methods Mol Biol., Humana Press, Totowa, NJ, USA, 2010, 607:73-83.
51.
Sattabongkot J, Han ET.
Detection of Plasmodium vivax infection in the Republic of Korea by loop-mediated isothermal amplification (LAMP).
Acta Trop. 2010, 113: 61–65.
50.
Morales, J., Mogi, T., Mineki, S., Takashima, E., Mineki, R., Hirawake, H., Sakamoto, K., Omura, S., Kita, K.
Novel mitochondrial complex II isolated from Trypanosoma cruzi is composed of twelve peptides including a heterodimeric Ip subunit.
J Biol Chem. 2009; 284(11):7255-63.
49.
Arakawa T, Tachibana M, Miyata T, Harakuni T, Kohama H, Matsumoto Y, Tsuji N, Hisaeda H, Stowers A, Torii M, Tsuboi T.
Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.
Infect Immun, 2009, 77: 5496–5500.
48.
Takeo S, Arumugam TU, Torii M, Tsuboi T.
Wheat germ cell-free technology for accelerating the malaria vaccine research.
Expert Opin Drug Discov. 2009, 4:1191-1199.
47.
Hayakawa T, Arisue N, Udono T, Hirai H, Sattabongkot J, Toyama T, Tsuboi T, Horii T, Tanabe K.
Identification of Plasmodium malariae, a human malaria parasite, in imported chimpanzees.
PLoS ONE. 2009, 4(10):e7412.
46.
Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, Takeo S, Tsuboi T, Yadava A, Carter R, Tanabe K.
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, west central Africa.
J Infect Dis. 2009, 200:1465-1469.
45.
Jiang G, Shi M, Conteh S, Richie N, Banania G, Geneshan H, Valencia A, Singh P, Aguiar J, Limbach K, Kamrud KI, Rayner J, Smith J, Bruder JT, King CR, Tsuboi T, Takeo S, Endo Y, Doolan DL, Richie TL, Weiss WR.
Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
PLoS ONE. 2009, 4(8):e6559.
44.
VanBuskirk KM, O’Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, Dowler MG, Sacci, Jr. JB, Kangwanrangsan N, Tsuboi T, Kneteman NM, Heppner, Jr. DG, Murdock BA, Mikolajczak SA, Aly ASI, Cowman AF Kappe SHI.
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.
Proc Natl Acad Sci U S A. 2009, 106:13004-13009.
43.
Shen C, Lee J-A, Allam SRA, Bae Y-M, Han E-T, Takeo S, Tsuboi T, Hong S-T, Choi M-H.
Serodiagnostic applicability of recombinant antigens of Clonorchis sinensis
expressed by wheat germ cell-free protein synthesis system.
Diagn Microbiol Infect Dis. 2009, 64:334-339.
42.
Takeo S, Hisamori D, Matsuda S, Vinetz J, Sattabongkot J, Tsuboi T.
Enzymatic characterization of the Plasmodium vivax chitinase, a potential malaria transmission-blocking target.
Parasitol Int. 2009, 58:243-248.
41.
Otsuki H, Kaneko O, Thongkukiatkul A, Tachibana M, Iriko H, Takeo S, Tsuboi T, Torii M.
Single amino acid substitution in Plasmodium yoelii erythrocyte ligand determines its localization and controls parasite virulence.
Proc Natl Acad Sci U S A. 2009, 106:7167-7172.
40.
Iriko H, Jin L, Kaneko O, Takeo S, Han ET, Tachibana M, Otsuki H, Torii M, Tsuboi T.
A small-scale systematic analysis of alternative splicing in Plasmodium falciparum.
Parasitol Int. 2009, 58:196-199.
39.
Maeda T, Saito T, Harb OS, Roos DS, Takeo S, Suzuki H, Tsuboi T, Takeuchi T, Asai T.
Pyruvate kinase type-II isozyme in Plasmodium falciparum localizes to the apicoplast. Parasitol. Int. 2009, 58:101-105.
38.
Harakuni T, Kohama H, Tadano M, Uechi G, Tsuji N, Matsumoto Y, Miyata T, Tsuboi T, Oku H, Arakawa T.
Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
Jpn J Infect Dis. 2009, 62:37-45.
37.
Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, Tsuboi T, Torii M.
Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites.
Parasitol Int. 2009, 58:29-35.
36.
Urano-Tashiro, Y., Yajima, A., Takashima, E., Takahashi, Y., Konishi, K.
Binding of the Streptococcus gordonii DL1 surface protein Hsa to the host cell membrane glycoproteins CD11b, CD43, and CD50.
Infect Immun. 2008; 76(10):4686-91
35.
Shimazu, K., Takahashi, Y., Uchikawa, Y., Shimazu, Y., Yajima, A., Takashima, E., Aoba, T., Konishi, K.
Identification of the Streptococcus gordonii glmM gene encoding phosphoglucosamine mutase and its role in bacterial cell morphology, biofilm formation and sensitivity to antibiotics.
FEMS Immunol Med Microbiol. 2008; 53(2):166-77
34.
Yajima, A., Urano-Tashiro, Y., Shimazu, K., Takashima, E., Takahashi, Y., Konishi, K
Hsa, an Adhesin of Streptococcus gordonii DL1, binds toα2-3–Linked Sialic Acid on Glycophorin A of the Erythrocyte Membrane.
Microbiol Immunol. 2008; 52(2):69–77
33.
Yano K, Otsuki H, Arai M, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S, Kawazu S.
Disruption of the Plasmodium berghei 2-Cys peroxiredoxin TPx-1 gene hinders the sporozoite development in the vector mosquito.
Mol Biochem Parasitol. 2008, 159:142-145.
32.
Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, Han ET, Otsuki H, Kaneko O, Sattabongkot J, Udomsangpetch R, Sawasaki T, Torii M, Endo Y.
Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates.
Infect Immun. 2008, 76:1702-1708.
31.
Iriko H, Kaneko O, Otsuki H, Tsuboi T, Su XZ, Tanabe K, Torii M.
Diversity and evolution of the rhoph1/clag multigene family of Plasmodium falciparum.
Mol Biochem Parasitol. 2008, 158:11-21.
30.
Yamada, H., Takashima, E., Konishi, K.
Molecular characterization of the membrane-bound quinol peroxidase functionally connected to the respiratory chain.
FEBS J. 2007; 274(3):853-66
29.
Katsube T, Matsumoto S, Takatsuka M, Okuyama M, Ozeki Y, Naito M, Nishiuchi Y, Fujiwara N, Yoshimura M, Tsuboi T, Torii M, Oshitani N, Arakawa T, Kobayashi K.
Control of cell wall assembly by a histone-like protein in mycobacteria.
J Bacteriol. 2007, 189:8241-8249.
28.
Han ET, Watanabe R, Sattabongkot J, Khuntirat B, Sirichaisinthop J, Iriko H, Jin L, Takeo S, Tsuboi T.
Detection of four Plasmodium species by genus- and species-specific loop-mediated isothermal amplification for clinical diagnosis.
J Clin Microbiol. 2007, 45:2521-2528.
27.
Kobayashi F, Waki S, Niikura M, Tachibana M, Tsuboi T, Torii M, Kamiya S.
Plasmodium berghei XAT: Protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
Exp Parasitol. 2007, 116:450-457.
26.
Ghoneim A, Kaneko O, Tsuboi T, Torii M.
The Plasmodium falciparum RhopH2 promoter and first 24 amino acids are sufficient to target proteins to the rhoptries.
Parasitol Int. 2007, 56:31-43.
25.
Mudeppa DG, Pang CKT, Tsuboi T, Endo Y, Buckner FS, Varani G, Rathod PK.
Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
Mol Biochem Parasitol. 2007, 151:216-219.
24.
Takahashi, Y., Takashima, E., Shimazu, K., Yagishita, H., Aoba, T., Konishi, K.
Contribution of sialic acid-binding adhesin to pathogenesis of experimental endocarditis caused by Streptococcus gordonii DL1.
Infect Immun. 2006; 74(1):740-3
23.
Han E-T, Lee D-H, Park K-D, Seok W-S, Kim Y-S, Tsuboi T, Shin E-H, Chai J-Y.
Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea.
Korean J. Parasitol. 2006, 44:285-294.
22.
Palacpac NM, Leung BW, Arisue N, Tanabe K, Sattabongkot J, Tsuboi T, Torii M, Udomsangpetch R, Horii T.
Plasmodium vivax serine repeat antigen (SERA) multigene family exhibits similar expression patterns in independent infections.
Mol. Biochem. Parasitol. 2006, 150:353-358.
20.
Kaneko O, Templeton TJ, Iriko H, Tachibana M, Otsuki H, Takeo S, Sattabongkot J, Torii M, Tsuboi T.
The Plasmodium vivax homolog of the ookinete adhesive micronemal protein, CTRP.
Parasitol. Int. 2006, 55:227-231.
19.
Yano K, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S, Kawazu S.
2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei.
Mol. Biochem. Parasitol. 2006, 148:44-51.
18.
Inaoka, D.K., Takashima, E., Osanai, A., Shimizu, H., Nara, T., Aoki, T., Harada, S., Kita, K.
Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005; 61(Pt 10):875-8. Epub 2005 Sep 13
17.
Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Infect. Immun. 2005, 73:7375-7380.
16.
Sawasaki T, Gouda MD, Kawasaki T, Tsuboi T, Tozawa Y, Takai K, Endo Y.
The wheat germ cell-free expression system: Methods for high-throughput materialization of genetic information. In Chemical Genomics: Reviews and protocols. Ed. Zanders ED.
Methods in Mol. Biol. 310: 131-144, Humana Press, Totowa, NJ, 2005.
15.
Kaneko O, Yim-Lim BYS, Iriko H, Ling IT, Otsuki H, Grainger M, Tsuboi T, Adams JH, Mattei D, Holder AA, Torii M.
Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex.
Mol. Biochem. Parasitol. 2005, 143:20-28.
14.
Rungruang T, Kaneko O, Murakami Y, Tsuboi T, Hamamoto H, Akimitsu N, Sekimizu K, Kinoshita T, Torii M.
Erythrocyte surface glycosylphosphatidyl inositol anchored receptor for the malaria parasite.
Mol. Biochem. Parasitol. 2005, 140:13-21.
13.
Win TT, Jalloh A, Tantular IS, Tsuboi T, Ferreira MU, Kimura M, Kawamoto F.
Molecular analysis of Plasmodium ovale variants.
Emerg. Infect. Dis. 2004, 10: 1235-1240.
12.
Kongkasuriyachai D, Bartels-Andrews L, Stowers A, Collins WE, Sullivan J, Sattabongkot J, Torii M, Tsuboi T, Kumar N.
Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28 – evaluation of homologous and heterologous antigen-delivery prime-boost strategy.
Vaccine 2004, 22: 3205-3213.
11.
Li F, Templeton TJ, Popov VL, Comer JE, Tsuboi T, Torii M, Vinetz JM.
Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission.
J. Biol. Chem. 2004, 279: 26635-26644.
10.
Tsuboi T, Kaneko O, Cao Y-M, Tachibana M, Yakushijin Y, Nagao T, Kanbara H, Torii M.
A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28.
Parasitol. Int. 2004, 53: 211-216.
9.
Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L.
Plasmodium vivax transmission: chances for control?
Trends Parasitol. 2004, 20: 192-198.
8.
Ling IT, Florens L, Dluzewski AR, Kaneko O, Grainger M, Yim- Lim BYS, Tsuboi T, Hopkins JM, Johnson JR, Torii M , Bannister LH, Yates JR 3rd, Holder AA, Mattei D.
The Plasmodium falciparum clag9 gene encodes a rhoptry protein that is transferred to the host erythrocyte upon invasion.
Mol. Microbiol. 2004, 52:107-118.
7.
Mi-Ichi F, Takeo S, Takashima E, Kobayashi T, Kim HS, Wataya Y, Matsuda A, Torii M, Tsuboi T, Kita K. Unique properties of respiratory chain in Plasmodium falciparum mitochondria.
Adv Exp Med Biol. 2003, 531: 117-133.
6.
Kawazu S, Nozaki T, Tsuboi T, Nakano Y, Komaki-Yasuda K, Ikenoue N, Torii M, Kano S. Expression profiles of peroxiredoxin proteins of the rodent malaria parasite Plasmodium yoelii.
Int. J. Parasitol. 2003, 33: 1455-1461.
5.
Sattabongkot J, Tsuboi T, Hisaeda H, Tachibana M, Suwanabun N, Rungruang T, Cao Y-M, Stowers A, Sirichaisinthop J, Coleman RE, Torii M.
Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.
Am. J. Trop. Med. Hyg. 2003, 69: 536-541.
4.
Tsuboi T, Kaneko O, Eitoku C, Suwanabun N, Sattabongkot J, Vinetz JM, Torii M.
Gene structure and ookinete expression of the chitinase genes of Plasmodium vivax and Plasmodium yoelii.
Mol. Biochem. Parasitol. 2003, 130:51-54.
3.
Arakawa T, Tsuboi T, Kishimoto A, Sattabongkot J, Suwanabun N, T Rungruang, Matsumoto Y, Tsuji N, Hisaeda H, Stowers A, Shimabukuro I, Sato Y, Torii M.
Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes.
Vaccine 2003, 21:3143-3148.
2.
Ling IT, Kaneko O, Narum D, Tsuboi T, Howell S, Taylor HM, Scott-Finnigan TJ, Torii M, Holder AA.
Characterisation of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii.
Mol. Biochem. Parasitol. 2003, 127:47-57.
1.
Tsuboi T, Tachibana M, Kaneko O, Torii M.
Transmission-blocking vaccine of vivax malaria.
Parasitol. Int. 2003, 52:1-11.